Medical News and Perspectives |

Race Is On for Effective Dengue Vaccine

Rebecca Voelker
JAMA. 2010;304(13):1430-1431. doi:10.1001/jama.2010.1386.
Text Size: A A A
Published online


Adriane Cross Trout, MD, had only a few puzzling clues. Her patient had fever and intense retro-orbital headache. Treatment for a presumed urinary tract infection provided no relief. Tests were positive for Romberg sign, but negative for meningitis. Severe joint aches developed, as well as a few particularly revealing symptoms: petechial rash, thrombocytopenia, and atypical lymphocytes.

“I knew I was dealing with some kind of virus, but frankly, I didn't really know what was going on,” said Trout, a family physician in Rochester, NY. She heard the proverbial hoof beats, but knew it was time to think zebras, not horses. Trout consulted Mark Shelly, MD, an infectious disease specialist she had worked with during her residency. Her patient recently had traveled to Key West, Fla, another critical clue that led Trout and Shelly to the correct diagnosis: dengue.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Viruses that cause dengue pose complex challenges in vaccine development. A tetravalent vaccine is needed to protect against 4 serotypes of related flaviviruses.

(Photo credit: London School of Hygiene and Tropical Medicine/www.sciencesource.com)



Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles